日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Molecular Deconvolution of Circulating "Other Cells": A Reliable Predictive Marker of Therapy Response and Survival in Neuroendocrine Tumor Patients Receiving (177)Lu-DOTATATE PRRT

循环“其他细胞”的分子解卷积：接受 (177)Lu-DOTATATE PRRT 治疗的神经内分泌肿瘤患者治疗反应和生存的可靠预测标志物

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71444
Padwal, Mahesh K; Parghane, Rahul V; Basu, Sandip; Basu, Bhakti
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Developing a peripheral blood RNA-seq based NETseq ensemble classifier: A potential novel tool for non-invasive detection and treatment response assessment in neuroendocrine tumor patients receiving (177)Lu-DOTATATE PRRT

开发基于外周血RNA测序的NETseq集成分类器：一种用于接受(177)Lu-DOTATATE PRRT治疗的神经内分泌肿瘤患者的非侵入性检测和治疗反应评估的潜在新型工具

期刊:Journal of Neuroendocrinology
影响因子:4.1
doi:10.1111/jne.13462
Padwal, Mahesh K; Parghane, Rahul V; Chakraborty, Avik; Ujaoney, Aman Kumar; Anaganti, Narasimha; Basu, Sandip; Basu, Bhakti
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

PReCedeNT 试验：一项 III 期随机对照试验，比较镥-177 DOTATATE 肽受体放射性核素疗法 (PRRT) 联合化疗与单独使用 PRRT 治疗 FDG 亲和力高分化胃肠胰神经内分泌肿瘤 (GEP-NET) 的疗效。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15111-x
Puranik, Ameya D; Dev, Indraja D; Yadav, Sushil; Rangarajan, Venkatesh; Agrawal, Archi; Basu, Sandip; Chaudhari, Vikram A; Ramaswamy, Anant; Ostwal, Vikas; Bhandare, Manish S; Shrikhande, Shailesh V; Parghane, Rahul V; Bhargava, Prabhat; Bal, Munita M; Yadav, Subhash; Patkar, Shraddha; Goel, Mahesh; Purandare, Nilendu C; Shah, Sneha; Choudhury, Sayak; Ghosh, Suchismita; Venkatachalam, Manikandan
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in (177)Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors

评估治疗前中性粒细胞与淋巴细胞比值和单核细胞与淋巴细胞比值在接受 (177)Lu-DOTATATE PRRT 治疗的晚期转移性神经内分泌肿瘤患者中的预后意义

期刊:Endocrine
影响因子:2.9
doi:10.1007/s12020-025-04212-z
Padwal, Mahesh K; Nazar, Amir K; Parghane, Rahul V; Basu, Sandip; Basu, Bhakti
单核细胞
中性粒细胞
肿瘤
细胞生物学
肿瘤免疫
粒细胞
发表日期：2025
文献求助 收藏

Progressive Unilateral Proptosis and [ (18) F]FDG-Avid Lesions Connoting Aggressive Disease in Radioiodine-Refractory Differentiated Thyroid Carcinoma

进行性单侧眼球突出和[(18)F]FDG高摄取病灶提示放射性碘难治性分化型甲状腺癌的侵袭性疾病

期刊:World Journal of Nuclear Medicine
影响因子:0.9
doi:10.1055/s-0044-1792029
Edamadaka, Yeshwanth; Parghane, Rahul V; Basu, Sandip
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Rare Combination of Multiple Endocrine Neoplasia 1 with Medullary Thyroid Carcinoma and Clinical Value of (68) Ga-DOTATATE PET/CT in Diagnosing Different Lesions and Exploring Theranostic Strategy

多发性内分泌肿瘤1型合并甲状腺髓样癌的罕见病例，以及(68)Ga-DOTATATE PET/CT在诊断不同病变和探索诊疗一体化策略中的临床价值

期刊:World Journal of Nuclear Medicine
影响因子:0.9
doi:10.1055/s-0044-1791818
Baberwal, Parth; Parghane, Rahul V; Basu, Sandip
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Tissue and Organ-specific Tumor Heterogeneity on dual tracer PET-CT ([(68)Ga] Ga-PSMA-11 and [(18)F] FDG) and Dural-based Brain metastasis in Metastatic Prostate Cancer

双示踪剂PET-CT（[(68)Ga]Ga-PSMA-11和[(18)F]FDG）及转移性前列腺癌脑转移灶的组织和器官特异性肿瘤异质性

期刊:Indian Journal of Nuclear Medicine
影响因子:0.5
doi:10.4103/ijnm.ijnm_44_25
Edamadaka, Yeshwanth; Parghane, Rahul V; Basu, Sandip
肿瘤异质性
神经科学
前列腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors

影响转移性1级胃肠胰神经内分泌肿瘤预后的因素

期刊:Journal of Gastrointestinal Cancer
影响因子:1.6
doi:10.1007/s12029-024-01077-9
Pandrowala, Saneya A; Kapoor, Deeksha; Kunte, Aditya; Chopde, Amit; Puranik, Ameya; Dev, Indraja Devidas; Parghane, Rahul; Basu, Sandip; Ramaswamy, Anant; Ostwal, Vikas; Chaudhari, Vikram A; Bhandare, Manish S; Shrikhande, Shailesh V
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of (131) I-Whole-Body Scintigraphy with Regional SPECT/CT

分化型甲状腺癌患者出现非典型临床表现时，其转移部位异常及放射性碘摄取情况：应用（131）I全身闪烁显像联合区域SPECT/CT进行研究

期刊:World Journal of Nuclear Medicine
影响因子:0.9
doi:10.1055/s-0044-1779750
Edamadaka, Yeshwanth; Parghane, Rahul V; Basu, Sandip
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors

[18F]FDG 和 [18F]NaF-PET/CT 在评估伴有棕色瘤的同步性甲状腺癌和甲状旁腺腺瘤中的互补作用

期刊:World Journal of Nuclear Medicine
影响因子:0.9
doi:10.1055/s-0044-1787732
Edamadaka, Yeshwanth; Parghane, Rahul V; Basu, Sandip
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏